These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1279 related articles for article (PubMed ID: 33215344)

  • 41. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Use of Stereotactic Radiosurgery in the Treatment of Adults With Metastatic Brain Tumors.
    Graber JJ; Cobbs CS; Olson JJ
    Neurosurgery; 2019 Mar; 84(3):E168-E170. PubMed ID: 30629225
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Canadian recommendations for the treatment of glioblastoma multiforme.
    Mason WP; Maestro RD; Eisenstat D; Forsyth P; Fulton D; Laperrière N; Macdonald D; Perry J; Thiessen B;
    Curr Oncol; 2007 Jun; 14(3):110-7. PubMed ID: 17593983
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of neuropathology in the management of newly diagnosed glioblastoma: a systematic review and evidence-based clinical practice guideline.
    Velázquez Vega JE; Brat DJ; Ryken TC; Olson JJ
    J Neurooncol; 2020 Nov; 150(2):143-164. PubMed ID: 33215342
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of moderately hypofractionated simultaneous integrated boost intensity-modulated radiotherapy combined with temozolomide for the postoperative treatment of glioblastoma multiforme: a single-institution experience.
    Zhong L; Chen L; Lv S; Li Q; Chen G; Luo W; Zhou P; Li G
    Radiat Oncol; 2019 Jun; 14(1):104. PubMed ID: 31196126
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of elderly patients with glioblastoma: a systematic evidence-based analysis.
    Zarnett OJ; Sahgal A; Gosio J; Perry J; Berger MS; Chang S; Das S
    JAMA Neurol; 2015 May; 72(5):589-96. PubMed ID: 25822375
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Radiosurgery and Radiation Therapy in the Management of Patients With Vestibular Schwannomas.
    Germano IM; Sheehan J; Parish J; Atkins T; Asher A; Hadjipanayis CG; Burri SH; Green S; Olson JJ
    Neurosurgery; 2018 Feb; 82(2):E49-E51. PubMed ID: 29309637
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Accelerated hypofractionated radiation for elderly or frail patients with a newly diagnosed glioblastoma: A pooled analysis of patient-level data from 4 prospective trials.
    Perlow HK; Prasad RN; Yang M; Klamer B; Matsui J; Marrazzo L; Detti B; Scorsetti M; Clerici E; Arnett A; Beyer S; Ammirati M; Chakravarti A; Raval RR; Brown PD; Navarria P; Scoccianti S; Grecula JC; Palmer JD
    Cancer; 2022 Jun; 128(12):2367-2374. PubMed ID: 35315512
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Accelerated Hypofractionated Radiotherapy in the Era of Concurrent Temozolomide Chemotherapy in Elderly Patients with Glioblastoma Multiforme.
    Greer L; Pannullo SC; Smith AW; Taube S; Yondorf MZ; Parashar B; Trichter S; Nedialkova L; Sabbas A; Christos P; Wernicke AG
    Cureus; 2017 Jun; 9(6):e1388. PubMed ID: 28775928
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Upfront boost Gamma Knife "leading-edge" radiosurgery to FLAIR MRI-defined tumor migration pathways in 174 patients with glioblastoma multiforme: a 15-year assessment of a novel therapy.
    Duma CM; Kim BS; Chen PV; Plunkett ME; Mackintosh R; Mathews MS; Casserly RM; Mendez GA; Furman DJ; Smith G; Oh N; Caraway CA; Sanathara AR; Dillman RO; Riley AS; Weiland D; Stemler L; Cannell R; Abrams DA; Smith A; Owen CM; Eisenberg B; Brant-Zawadzki M
    J Neurosurg; 2016 Dec; 125(Suppl 1):40-49. PubMed ID: 27903197
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme.
    Chang JE; Khuntia D; Robins HI; Mehta MP
    Clin Adv Hematol Oncol; 2007 Nov; 5(11):894-902, 907-15. PubMed ID: 18185489
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma.
    Ney DE; Carlson JA; Damek DM; Gaspar LE; Kavanagh BD; Kleinschmidt-DeMasters BK; Waziri AE; Lillehei KO; Reddy K; Chen C
    J Neurooncol; 2015 Mar; 122(1):135-43. PubMed ID: 25524817
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
    Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
    Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Standard fractionation intensity modulated radiation therapy (IMRT) of primary and recurrent glioblastoma multiforme.
    Fuller CD; Choi M; Forthuber B; Wang SJ; Rajagiriyil N; Salter BJ; Fuss M
    Radiat Oncol; 2007 Jul; 2():26. PubMed ID: 17629934
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Narrative review of palliative hypofractionated radiotherapy for high grade glioma.
    Saeed H; Tseng YD; Lo SS
    Ann Palliat Med; 2021 Jan; 10(1):846-862. PubMed ID: 33040565
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of elderly patients with glioblastoma: current status with a focus on the post-operative radiation therapy.
    de Melo SM; Marta GN; Yan M; Cruz C; Moraes FY; Riera R
    Ann Palliat Med; 2020 Sep; 9(5):3553-3561. PubMed ID: 32819127
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of radiation therapy and radiosurgery in glioblastoma multiforme.
    Fiveash JB; Spencer SA
    Cancer J; 2003; 9(3):222-9. PubMed ID: 12952307
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A randomized phase III study of short-course radiotherapy combined with Temozolomide in elderly patients with newly diagnosed glioblastoma; Japan clinical oncology group study JCOG1910 (AgedGlio-PIII).
    Arakawa Y; Sasaki K; Mineharu Y; Uto M; Mizowaki T; Mizusawa J; Sekino Y; Ono T; Aoyama H; Satomi K; Ichimura K; Kinoshita M; Ohno M; Ito Y; Nishikawa R; Fukuda H; Nishimura Y; Narita Y;
    BMC Cancer; 2021 Oct; 21(1):1105. PubMed ID: 34654402
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme.
    Mizumoto M; Tsuboi K; Igaki H; Yamamoto T; Takano S; Oshiro Y; Hayashi Y; Hashii H; Kanemoto A; Nakayama H; Sugahara S; Sakurai H; Matsumura A; Tokuuye K
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):98-105. PubMed ID: 19695794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.
    Nelson DF; Curran WJ; Scott C; Nelson JS; Weinstein AS; Ahmad K; Constine LS; Murray K; Powlis WD; Mohiuddin M
    Int J Radiat Oncol Biol Phys; 1993 Jan; 25(2):193-207. PubMed ID: 8380567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 64.